| Record ID | marc_loc_2016/BooksAll.2016.part30.utf8:196442873:1341 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part30.utf8:196442873:1341?format=raw |
LEADER: 01341cam a22003374a 4500
001 2003056983
003 DLC
005 20130523090516.0
008 031015s2004 nyu b 001 0beng
010 $a 2003056983
020 $a0060555564
040 $aDLC$cDLC$dDLC
042 $apcc
043 $an-us---
050 00 $aHD9675.A672$bW35 2004
082 00 $a338.7/61616994061/092$aB$222
100 1 $aPrud'homme, Alex.
245 14 $aThe cell game :$bSam Waksal's fast money and false promises--and the fate of ImClone's cancer drug /$cAlex Prud'homme.
260 $aNew York :$bHarperBusiness,$cc2004.
300 $axviii, 412 p. ;$c24 cm.
504 $aIncludes bibliographical references and index.
600 10 $aWaksal, Samuel David.
610 20 $aImClone Systems Incorporated$xHistory.
650 0 $aBusinessmen$zUnited States$vBiography.
650 0 $aAntineoplastic agents industry$xCorrupt practices$zUnited States.
650 0 $aMonoclonal antibodies$xResearch$zUnited States$xHistory.
650 0 $aCancer$xChemotherapy.
650 0 $aDrugs$zUnited States$xTesting.
650 0 $aInsider trading in securities$zUnited States.
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/fy051/2003056983.html
856 42 $3Contributor biographical information$uhttp://www.loc.gov/catdir/enhancements/fy1308/2003056983-b.html